AAAAAA

   
Results: 1-10 |
Results: 10
Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug
Authors: Alberts, DS Hallum, AV Stratton-Custis, M Garcia, DJ Gleason-Guzman, M Salmon, SE Santabarbara, P Niesor, EJ Floret, S Bentzen, CL
Citation: Ds. Alberts et al., Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug, CLIN CANC R, 7(5), 2001, pp. 1246-1250
The determination of wheat breadmaking performance and bread dough mixing time by NIR spectroscopy for high speed mixers
Authors: Alava, JM Millar, SJ Salmon, SE
Citation: Jm. Alava et al., The determination of wheat breadmaking performance and bread dough mixing time by NIR spectroscopy for high speed mixers, J CEREAL SC, 33(1), 2001, pp. 71-81
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugatedL-asparaginase in patients with advanced solid tumors
Authors: Taylor, CW Dorr, RT Fanta, P Hersh, EM Salmon, SE
Citation: Cw. Taylor et al., A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugatedL-asparaginase in patients with advanced solid tumors, CANC CHEMOT, 47(1), 2001, pp. 83-88
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
Authors: Flanigan, RC Salmon, SE Blumenstein, BA Bearman, SI Roy, V McGrath, PC Caton, JR Munshi, N Crawford, ED
Citation: Rc. Flanigan et al., Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer, N ENG J MED, 345(23), 2001, pp. 1655-1659
cDNA microarray analysis of multidrug resistance: Doxorubicin selection produces multiple defects in apoptosis signaling pathways
Authors: Watts, GS Futscher, BW Isett, R Gleason-Guzman, M Kunkel, MW Salmon, SE
Citation: Gs. Watts et al., cDNA microarray analysis of multidrug resistance: Doxorubicin selection produces multiple defects in apoptosis signaling pathways, J PHARM EXP, 299(2), 2001, pp. 434-441
Variation in the breadmaking quality and rheological properties of wheat in relation to sulphur nutrition under field conditions
Authors: Zhao, FJ Salmon, SE Withers, PJA Monaghan, JM Evans, EJ Shewry, PR McGrath, SP
Citation: Fj. Zhao et al., Variation in the breadmaking quality and rheological properties of wheat in relation to sulphur nutrition under field conditions, J CEREAL SC, 30(1), 1999, pp. 19-31
High-dose melphalan with autotransplantation for refractory multiple myeloma: Results of a southwest oncology group phase II trial
Authors: Vesole, DH Crowley, JJ Catchatourian, R Stiff, PJ Johnson, DB Cromer, J Salmon, SE Barlogie, B
Citation: Dh. Vesole et al., High-dose melphalan with autotransplantation for refractory multiple myeloma: Results of a southwest oncology group phase II trial, J CL ONCOL, 17(7), 1999, pp. 2173-2179
Responses of breadmaking quality to sulphur in three wheat varieties
Authors: Zhao, FJ Salmon, SE Withers, PJA Evans, EJ Monaghan, JM Shewry, PR McGrath, SP
Citation: Fj. Zhao et al., Responses of breadmaking quality to sulphur in three wheat varieties, J SCI FOOD, 79(13), 1999, pp. 1865-1874
Novel antitumor 2-cyanoaziridine-1-carboxamides
Authors: Iyengar, BS Dorr, RT Alberts, DS Hersh, EM Salmon, SE Remers, WA
Citation: Bs. Iyengar et al., Novel antitumor 2-cyanoaziridine-1-carboxamides, J MED CHEM, 42(3), 1999, pp. 510-514
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers
Authors: Monk, BJ Alberts, DS Burger, RA Fanta, PT Hallum, AV Hatch, KD Salmon, SE
Citation: Bj. Monk et al., In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers, GYNECOL ONC, 71(2), 1998, pp. 308-312
Risultati: 1-10 |